Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice

BACKGROUND: The poor prognosis of patients with colorectal-cancer liver metastases (CRLM) and the insufficiency of available treatments have raised the need for alternative curative strategies. We aimed to assess the therapeutic potential of TL-118, a new anti-angiogenic drug combination, for CRLM t...

Descripción completa

Detalles Bibliográficos
Autores principales: Edrei, Y, Gross, E, Corchia, N, Abramovitch, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419965/
https://www.ncbi.nlm.nih.gov/pubmed/22805330
http://dx.doi.org/10.1038/bjc.2012.322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419965/
https://www.ncbi.nlm.nih.gov/pubmed/22805330
http://dx.doi.org/10.1038/bjc.2012.322

Ejemplares similares